Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 7 November 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Orders for the company's mainstay tuning-fork crystal resonators recovered, particularly for smartphones and medical and healthcare applications. In addition, profitability improved as a result of higher productivity and changes in the product mix, substantially reducing losses.
| Item | Details |
|---|---|
| Net Sales | ¥5,740 million → ¥5,784 million（0.8％） |
| Operating profit | ¥-224 million → ¥-70 million |
| Ordinary income | ¥-235 million → ¥-54 million |
| Profit attributable to owners of the parent | ¥-266 million → ¥-12 million |
| Net income per share | -32.42 yen and sen → -1.48 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 7 November 2025 |
| Previous-period results | Revenue ¥5,698 million, operating loss ¥75 million, ordinary loss ¥60 million, net loss attributable to owners of the parent ¥79 million, and loss per share of ¥9.66 (fiscal year ended March 2025) |
| Reason for the revision | Orders for the company's mainstay tuning-fork crystal resonators recovered, particularly for smartphones and medical and healthcare applications. In addition, profitability improved as a result of higher productivity and changes in the product mix, substantially reducing losses. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Orders for tuning-fork crystal resonators recovered, particularly for smartphones and medical and healthcare applications. In addition, profitability improved as a result of higher productivity and changes in the product mix.